Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 84 of 95, showing 5 Applications out of 471 total, starting on record 416, ending on 420

# Protocol No Study Title Investigator(s) & Site(s)

416.

ECCT/13/07/03  
    Pharmacokinetic and pharmacodynamic studies of efficacy, tolerability and safety of higher dosage rifapentine for treatment of tuberculosis   
Principal Investigator(s)
1. Dr Lena Matata
Site(s) in Kenya
KEMRI-CDC
 
View

417.

ECCT/13/07/01   HIVCORE004/N004
    A phase I/IIa clinical trial of universal HIV-1 vaccines pSG2.HIVconsv DNA, MVA.HIVconsv and ChAdV63.HIVconsv in combined regimens in healthy HIV-1/2-negative adults in Nairobi.   
Principal Investigator(s)
1. Prof. Walter Godfrey Jaoko
Site(s) in Kenya
KAVI-KANGEMI RESEARCH SITE
 
View

418.

ECCT/13/05/02  
    An open-label randomized controlled trial of the efficacy and safety of Clindamycin plus quinine compared with artemether-lumefantrine for the treatment of children with uncomplicated  falciparum malaria in western Kenya   
Principal Investigator(s)
1. CHARLES OWUORA OBONYO
Site(s) in Kenya
Ahero Sub-district Hospital
 
View

419.

ECCT/13/05/01  
    Use of the Shang Ring device in all four childhood age groups in the African population   
Principal Investigator(s)
1. Quentin David Awori
Site(s) in Kenya
Homa Bay District Hospital
 
View

420.

ECCT/13/04/09   Short-course RPT/INH for latent TB in HIV-infected individuals
        Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection   
Principal Investigator(s)
1. Deborah C. Langat
Site(s) in Kenya
1. Kenya Medical Research Institute Walter Reed Project Clinical Research Centre (Kericho county)
2. Moi University Clinical Research Centre (Uasin Gishu county)
 
View